$UXIN

Uxin Announces Adoption of Rule 10b5-1 Purchase Plan by Entity Controlled by Chairman and CEO

Uxin Limited (Nasdaq: UXIN) said its CEO Kun Dai’s controlled entity, Xin Gao Group Limited, entered a Rule 10b5-1 plan on June 30, 2026 to buy up to $5 million of Uxin ADS. Purchases are subject to conditions including a max price of $2.85 per ADS and can start Sept. 28, 2026.

Original reporting
Published Jul 1, 2026, 9:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 10:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$UXIN
Bullish
medium confidence
Mentioned
$UXIN
Relevance
5/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$UXINBullishLow
01

Why it matters

The key new information is the plan’s size (up to $5m), price condition (no more than $2.85 per ADS), and the delayed commencement date (Sep 28, 2026).

02

Market read

Traders may treat this as a modest insider-support signal, but the conditional and future-dated nature likely limits immediate price impact.

03

What to watch

Because purchases are conditional and start in late September, traders may overestimate near-term impact; monitor whether the ADS trades near/under $2.85 before Sep 28.

Relevance 5/10Novelty 5/10Timing: Authorized purchases can commence Sep 28, 2026 (after the 90-day cooling-off period).

Background

Uxin announced a pre-arranged Rule 10b5-1 purchase plan adopted by an entity controlled by its chairman/CEO, intended to satisfy the Rule 10b5-1 affirmative defense.

Company-level read

Ticker impact

$UXINBullishMedium confidence
Context

Uxin disclosed that its CEO-controlled entity entered a Rule 10b5-1 plan to buy up to $5m of UXIN ADS, capped at $2.85.

Expected impact

Likely modest support for sentiment; any price reaction should be muted until the plan’s authorized start date (Sep 28, 2026).

Evidence & confidence

The disclosure is a primary insider-trading-policy update with specific purchase limits and a future commencement date, which typically reduces immediate trading impact versus an open-market buy.

Market effects

Limited sector read-through; this is company-specific insider trading-plan mechanics rather than a used-car demand or regulatory development.

No direct regional macro linkage beyond general China equity sentiment.

Minimal; affects only UXIN’s ADS trading expectations around insider activity timing.

Counterpoint

A 10b5-1 plan can be pre-scheduled and may not reflect a fresh bullish view; the $2.85 cap could mean buys only occur if the stock weakens.

Key entities

  • Uxin Limited

    Nasdaq-listed used car retailer that disclosed the Rule 10b5-1 ADS purchase plan.

  • Kun Dai

    Chairman and CEO whose controlled entity entered the pre-arranged trading plan.

  • Xin Gao Group Limited

    Entity controlled by Kun Dai that will purchase up to $5m of Uxin ADS under the plan.

Related articles

$UXINMed

Uxin Q2 Loss Widens; Shares Up

Uxin Limited reported a wider net loss of RMB 183.33 million ($27.02 million) in Q2 2026, up from RMB 73.80 million a year ago, with total revenues increasing to RMB 1.151 billion ($169.66 million). The company forecasted Q3 revenue of RMB 1.16-1.19 billion and a gross profit margin above 6.0%. Shares rose 13.30% to $1.2350 on Nasdaq.

$UXINMed

Uxin Ltd (UXIN): Financial results for Q2 2026

Uxin Ltd (UXIN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 BEIJING, September 24, 2026 – Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced its unaudited financial results for the quarter ended

$UXINMed

Why is Uxin stock surging today?

Uxin (UXIN) stock rose 6.42% in pre-market trading after reporting Q2 2026 revenue of RMB1,151.2 million, up 74.9% YoY. The company projected Q3 revenue of RMB1,160-1,190 million and a gross profit margin above 6.0%, reversing a prior -0.7% margin. Management attributed margin weakness to temporary market conditions. The rally occurred despite broader market declines, highlighting company-specific optimism.

$UXINMed

Uxin Q1 Earnings Call Highlights

Uxin (NASDAQ: UXIN) reported Q1 adjusted EBITDA loss of CNY 34.3 million, widening sequentially from CNY 27.2 million, which management attributed to Chinese New Year seasonality and higher ramp-up and staffing costs. Management cited auto-market weakness: first five months’ new vehicle sales down 20% YoY and April-May ICE sales down over 35% YoY, with used ICE prices falling 10%-15% in 1-2 months. Uxin said gross margin may face more pressure in Q2, but expects improvement in Q3 if ICE prices s